Hui Xu

Title: Hui Xu - Innovator in CRISPR Technology

Introduction

Hui Xu is a prominent inventor based in Guangdong, China. She has made significant contributions to the field of genetic engineering, particularly through her work on the CRISPR-Cas13 system. Her innovative approach has the potential to revolutionize gene editing and therapeutic applications.

Latest Patents

Hui Xu holds a patent for the CRISPR-Cas13 system and its applications. The invention relates to a CRISPR-Cas13 system, which includes a Cas13 protein, a fusion protein, and a guide polynucleotide. The Cas13 protein exhibits at least 90% sequence identity compared to SEQ ID NO: 1. The fusion protein consists of the Cas13 protein fused to a protein domain and/or a polypeptide tag. The guide polynucleotide contains a same-direction repetition sequence and a guide sequence engineered to hybridize with target RNA. This innovative system has the potential to advance the field of RNA targeting and gene regulation.

Career Highlights

Hui Xu has worked with notable companies in the biotechnology sector, including Guangzhou Reforgene Medicine Co., Ltd. and Zhejiang Synsorbio Technology Co., Ltd. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Hui Xu has collaborated with esteemed colleagues such as Junbin Liang and Xingxiang Liang. These partnerships have fostered a dynamic research environment, enabling the development of innovative solutions in genetic engineering.

Conclusion

Hui Xu's contributions to the CRISPR-Cas13 system exemplify her dedication to advancing genetic research. Her innovative work continues to inspire future developments in biotechnology and gene therapy.